• 31ST MARCH 2023

    PSNC publishes TAPR Progress Report

    PSNC is continuing to make progress on addressing the Review Steering Group (RSG) proposals and has today published some resources to update contractors and LPCs on this work. PSNC is taking forward the RSG proposals directed at the Committee through its Transforming Pharmacy Representation (TAPR) work programme. The resources published include an update on the Transforming Pharmacy

    Read more
    • 31ST MARCH 2023

    2023 PSNC Election: West Midlands result and CCA nominees

    Voting has now closed in the ballot for the West Midlands Regional Representative on PSNC (soon to be known as Community Pharmacy England), and the Company Chemists’ Association (CCA) has nominated its representatives.   West Midlands Regional Representative Completed voting forms received by the close of voting (12 noon on Friday 31st March 2023) have

    Read more
    • 31ST MARCH 2023

    EpiPen reimbursement price redetermined for March 2023

    Following representations by PSNC on behalf of contractors the Department of Health and Social Care (DHSC) has redetermined the reimbursement prices for EpiPen preparations for March 2023 to reflect an increase in their NHS list price. On 1st March the list price of EpiPen preparations were increased by the manufacturer Viatris. DHSC have granted the following

    Read more
    • 31ST MARCH 2023

    March 2023 Price Concessions Final Update

    The Department of Health and Social Care (DHSC) has today (31/03/2023) granted the following final list of price concessions for March 2023. Drug Pack size Price concession Chlorphenamine 2mg/5ml oral solution 150 £3.72 Co-amoxiclav 250mg/125mg tablets 21 £2.94 Duloxetine 60mg gastro-resistant capsules 28 £3.84 Fusidic acid 1% modified-release eye drops 5 £31.41 Ivabradine 2.5mg tablets 56

    Read more
    • 31ST MARCH 2023

    Patient app use for ordering medicines

    Several international studies have concluded that patients with access to online features are more satisfied and that such features improve self-care along with patient’s communication and engagement with their clinicians. Community pharmacy organisations of all shapes and sizes are now supporting their patients with app and website offerings to enable patients to place medicine orders

    Read more
    • 31ST MARCH 2023

    Contractor Notice: Expiry of SSP005 Fluoxetine 10mg tablets

    The Department of Health and Social Care (DHSC) has confirmed that Serious Shortage Protocol (SSP), SSP005 Fluoxetine 10mg tablets expires at 23.59pm on Friday 31 March 2023. After this date SSP005 will no longer be valid for use. Top tips for SSP claims Where available, use the claim amend facility on the PMR system to

    Read more
    • 31ST MARCH 2023

    Rollout of HRT PPC begins from April

    The Government’s new Prescription Prepayment Certificate (PPC) for hormone replacement therapy (HRT) products comes into effect from tomorrow (1 April 2023). PSNC has been in discussion with the British Medical Association (BMA) about the impact of the new HRT PPC on working practices. Both we and the BMA are agreed on the importance of collaborative

    Read more
    • 31ST MARCH 2023

    Public overwhelmingly back Pharmacy First

    YouGov polling commissioned by PSNC has shown the strength of public support for pharmacies and for a Pharmacy First service. The results show the extent of the public backing for a Pharmacy First approach – PSNC has been arguing that a fully-funded service would be beneficial for pharmacies, patients and the wider NHS. And they

    Read more
    • 30TH MARCH 2023

    March 2023 Price Concessions 3rd Update

    The Department of Health and Social Care (DHSC) has today (30/03/2023) granted the following list of price concessions for March 2023. Drug Pack size Price concession Bicalutamide 150mg tablets 28 £3.96 Cefalexin 250mg tablets 28 £2.86 Cefalexin 500mg capsules 21 £2.80 Cefalexin 500mg tablets 21 £2.80 Cinnarizine 15mg tablets 84 £5.70 Clarithromycin 125mg/5ml oral suspension 70

    Read more
    • 30TH MARCH 2023

    MHRA Class 4 Medicines Defect Information: Briviact 75mg & 100mg film-coated tablets (Ethigen Limited)

    Class 4 Medicines Defect Information: Briviact 75mg & 100mg film-coated tablets (Ethigen Limited) Drug alert number: EL (23)A/13 Date issued: 30 March 2023 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Briviact 75 mg film-coated tablets,  PLPI 18716/0146  SNOMED Code: 37622711000001100 Batch number Expiry date

    Read more